Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2015 2
2016 3
2017 1
2018 3
2019 3
2020 4
2021 1
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12.
Kurokawa C, Agrawal S, Mitra A, Galvani E, Burke S, Varshine A, Rothstein R, Schifferli K, Monks NR, Foloppe J, Silvestre N, Quemeneur E, Demeusoit C, Kleinpeter P, Sapra P, Barrett C, Hammond SA, Kelly EJ, Laliberte J, Durham NM, Oberst M, Broggi MAS. Kurokawa C, et al. Among authors: foloppe j. Mol Ther Oncol. 2024 Jan 10;32(1):200758. doi: 10.1016/j.omton.2023.200758. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596304 Free PMC article.
Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors.
Béguin J, Laloy E, Cochin S, Gantzer M, Farine I, Pichon C, Moreau B, Foloppe J, Balloul JM, Machon C, Guitton J, Tierny D, Klonjkowski B, Quéméneur E, Maurey C, Erbs P. Béguin J, et al. Among authors: foloppe j. Mol Ther Oncolytics. 2023 Jul 20;30:103-116. doi: 10.1016/j.omto.2023.07.005. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37635744 Free PMC article.
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject 'cold' tumors.
Semmrich M, Marchand JB, Fend L, Rehn M, Remy C, Holmkvist P, Silvestre N, Svensson C, Kleinpeter P, Deforges J, Junghus F, Cleary KL, Bodén M, Mårtensson L, Foloppe J, Teige I, Quéméneur E, Frendéus B. Semmrich M, et al. Among authors: foloppe j. J Immunother Cancer. 2022 Jan;10(1):e003488. doi: 10.1136/jitc-2021-003488. J Immunother Cancer. 2022. PMID: 35058324 Free PMC article.
Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators.
Gallardo F, Schmitt D, Brandely R, Brua C, Silvestre N, Findeli A, Foloppe J, Top S, Kappler-Gratias S, Quentin-Froignant C, Morin R, Lagarde JM, Bystricky K, Bertagnoli S, Erbs P. Gallardo F, et al. Among authors: foloppe j. Biomedicines. 2020 Nov 26;8(12):543. doi: 10.3390/biomedicines8120543. Biomedicines. 2020. PMID: 33256205 Free PMC article.
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.
Béguin J, Foloppe J, Maurey C, Laloy E, Hortelano J, Nourtier V, Pichon C, Cochin S, Cordier P, Huet H, Quemeneur E, Klonjkowski B, Erbs P. Béguin J, et al. Among authors: foloppe j. Mol Ther Oncolytics. 2020 Sep 2;19:57-66. doi: 10.1016/j.omto.2020.08.020. eCollection 2020 Dec 16. Mol Ther Oncolytics. 2020. PMID: 33072863 Free PMC article.
High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma.
Delaunay T, Nader J, Grard M, Farine I, Hedwig V, Foloppe J, Blondy T, Violland M, Pouliquen D, Grégoire M, Boisgerault N, Erbs P, Fonteneau JF. Delaunay T, et al. Among authors: foloppe j. Mol Ther Oncolytics. 2020 Aug 25;18:573-578. doi: 10.1016/j.omto.2020.08.011. eCollection 2020 Sep 25. Mol Ther Oncolytics. 2020. PMID: 32995481 Free PMC article.
22 results